Pennsylvania Regulations: Communicable and Noncommunicable Diseases
Comment: Submitted to the Pennsylvania Department of Health
Policy
Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market
Briefing: Delivered to the Congressional Budget Office’s Panel of Health Advisors
Print:
In September, 2024, LDI Senior Fellow Abby Alpert, PhD briefed members of the Congressional Budget Office’s Panel of Health Advisors on the topic of vertical integration in the pharmaceutical market.
The briefing drew from Alpert’s research with a focus on Medicare Part D prescription drug plans and looked at the UnitedHealth-Catamaran merger in 2015 as a case study. Alpert found that premiums increased for non-vertically integrated insurers and that cost savings for the vertically integrated insurers were not passed through to enrollees in the form of lower premiums, and that vertical integration will reduce competition in the Medicare Part D market.
Views expressed by the researchers are their own and do not necessarily represent those of the University of Pennsylvania Health System (Penn Medicine) or the University of Pennsylvania.
More on Policy at LDI
Establishing a Strong Quantitative Medicine Innovation Network
Comment: Submitted to the Food and Drug Administration
Comments on the Regulation of Federal Financial Assistance
Comment: Delivered to the Office of Management and Budget
The State of LGBTQ+ Health in Philadelphia
Testimony: Delivered to Philadelphia City Council’s Committee on Public Health and Human Services by Amy Hillier
The State of LGBTQ+ Health in Philadelphia
Testimony: Delivered to Philadelphia City Council’s Committee on Public Health and Human Services by Aaron Richterman
Rural Health Transformation in Pennsylvania: Rural Access and Care Delivery
Testimony: Delivered to the Center for Rural Pennsylvania Board of Directors Public Hearing